T2 Biosystems Inc reports results for the quarter ended in September - Earnings Summary

T2 Biosystems

10/11/2022 23:17

* T2 Biosystems Inc  TTOO.OQ  reported a quarterly adjusted
loss
of $2.95​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of $2.04 per share.
    * Revenue fell 50.5% to $3.68 million from a year ago;
analysts
expected $5.90 million. 
    * T2 Biosystems Inc's reported EPS for the quarter was a
loss of
$2.95​.
    * The mean earnings estimate of analysts had risen by
about 31.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * T2 Biosystems Inc shares had fallen by 68.8% this
quarter and
lost 93.2% so far this year.
    * The company reported a quarterly loss of $17.71 million.
    * Wall Street's median 12-month price target for T2
Biosystems Inc
is $2.48 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:17 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -2.04          -2.95          Missed
 Jun. 30 2022      -4.50          -5.00          Missed
 Mar. 31 2022      -3.75          -5.00          Missed
 Dec. 31 2021      -4.50          -3.50          Beat